全文获取类型
收费全文 | 2875篇 |
免费 | 207篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 165篇 |
妇产科学 | 70篇 |
基础医学 | 322篇 |
口腔科学 | 54篇 |
临床医学 | 259篇 |
内科学 | 676篇 |
皮肤病学 | 58篇 |
神经病学 | 181篇 |
特种医学 | 289篇 |
外国民族医学 | 1篇 |
外科学 | 463篇 |
综合类 | 73篇 |
预防医学 | 229篇 |
眼科学 | 22篇 |
药学 | 112篇 |
中国医学 | 4篇 |
肿瘤学 | 156篇 |
出版年
2023年 | 17篇 |
2022年 | 24篇 |
2021年 | 53篇 |
2020年 | 40篇 |
2019年 | 55篇 |
2018年 | 69篇 |
2017年 | 59篇 |
2016年 | 53篇 |
2015年 | 54篇 |
2014年 | 68篇 |
2013年 | 88篇 |
2012年 | 122篇 |
2011年 | 147篇 |
2010年 | 108篇 |
2009年 | 105篇 |
2008年 | 139篇 |
2007年 | 154篇 |
2006年 | 117篇 |
2005年 | 103篇 |
2004年 | 91篇 |
2003年 | 109篇 |
2002年 | 94篇 |
2001年 | 94篇 |
2000年 | 77篇 |
1999年 | 69篇 |
1998年 | 69篇 |
1997年 | 69篇 |
1996年 | 79篇 |
1995年 | 46篇 |
1994年 | 49篇 |
1993年 | 32篇 |
1992年 | 55篇 |
1991年 | 65篇 |
1990年 | 39篇 |
1989年 | 66篇 |
1988年 | 64篇 |
1987年 | 52篇 |
1986年 | 50篇 |
1985年 | 31篇 |
1984年 | 27篇 |
1983年 | 21篇 |
1982年 | 31篇 |
1981年 | 23篇 |
1980年 | 29篇 |
1979年 | 25篇 |
1978年 | 11篇 |
1977年 | 15篇 |
1976年 | 11篇 |
1975年 | 11篇 |
1967年 | 10篇 |
排序方式: 共有3140条查询结果,搜索用时 0 毫秒
1.
Maren T Scheuner William C Whitworth Henraya McGruder Paula W Yoon Muin J Khoury 《Genetics in medicine》2006,8(8):525-531
PURPOSE: We examined the performance of a familial risk assessment method that stratifies risk for early-onset coronary heart disease by considering the number of relatives with coronary disease, degree of relationship, lineage, and age at diagnosis. METHODS: By using data from the HealthStyles 2003 survey, we assessed the associations between familial risk and early-onset coronary heart disease, diabetes, hypercholesterolemia, hypertension, and obesity. By using area under the curve statistics, we evaluated the discriminatory ability of various risk assessment models. RESULTS: Of 4,035 respondents, 60% were female and 72% were white, with a mean age of 48.8 years. After adjustment for demographics, strong and moderate risk were significantly associated with approximately a five- and twofold risk of early-onset coronary disease, respectively. After adjustment for demographics and personal history of cardiovascular disease, strong familial risk was also significantly associated with diabetes, hypercholesterolemia, hypertension, and obesity. A risk assessment model that included familial risk, demographics, and personal history of diabetes, hypercholesterolemia, hypertension, and obesity was most optimal with an area under the curve statistic of 87.2% CONCLUSIONS: Familial risk assessment can stratify risk for early-onset coronary heart disease. Several conditions associated with increased familial risk can be prevented. These results have important implications for risk assessment and risk-reducing interventions. 相似文献
2.
Birth weight on 12,644 singleton infants from 6,196 sibships born in Maryland between 1980 and 1984 were used to estimate the effects of nine maternal and infant covariates on the sibship correlation in birth weight. Assuming a homogeneous correlation across all families, the estimated intraclass correlation was 0.4664 (+/- 0.0099). This high sibship correlation makes it possible to predict, with reasonable accuracy, the birth weight of a child given information on previous sibs, as well as covariates on the mother and/or infant pertinent to a given pregnancy. The reduction in variance associated with incorporating information on the nine covariates used here was approximately equal to that obtained by conditioning on a single previous sib. Testing for heterogeneity in correlation among different groups of families showed that a crude measure of parity (first live birth vs. other), time between births, mother's marital status, and maternal age at the birth of the last child significantly influenced the sibship correlation in birth weight. 相似文献
3.
4.
The modulation of co-stimulatory pathways represents a novel therapeutic strategy to regulate autoimmune diseases. Auto-reactive
CD4+ T cells play a critical role in initiating the immune response leading to inflammation and autoimmune diseases. Blocking
co-stimulatory signals prevents T-cell activation, thus diminishing autoimmune responses and possibly preventing the progression
of autoimmune disease. Blockade of several co-stimulatory pathways has been investigated in animal models and has led to clinical
trials testing specific blocking agents in humans. In this review we will describe the role of co-stimulatory pathways, primarily
the CD28-B7 pathway, in autoimmune diseases, and we will present in vivo and in vitro studies supporting the efficacy of co-stimulation blockade in animal models of autoimmune disease. Finally, we will discuss
the clinical therapeutic efficacy of blocking monoclonal antibodies in preventing or reducing auto-antigen driven T-cell activation
in humans with particular attention to the CD28/B7 pathway. Inhibiting co-stimulatory molecule interactions by using monoclonal
antibodies seems to be an original approach to regulate autoimmune diseases in humans. 相似文献
5.
Cynthia J. Berg Jelka Zupan Philip J. d'Almada† Muin J. Khoury Lisa J. Fuller† ‡ 《Paediatric and perinatal epidemiology》1994,8(1):53-61
Summary. Very low birthweight (VLBW) is a commonly used endpoint in perinatal epidemiology, but the population of VLBW infants comprises a wide range of gestational ages and rates of fetal growth. We used data from a population-based study of all 1072 black and white VLBW liveborn infants born in 29 counties in Georgia between April 1986 and March 1988. Less than 1% of the VLBW infants were ≥ 37 weeks gestation; most were 29–32 weeks (26%) or 25 to 28 weeks (40%); 12% were 22 weeks or less. All infants 33 weeks gestation or greater were growth retarded. The population of VLBW infants seems to comprise three groups: approximately 11% very immature infants of 22 weeks or less; the majority of infants, born between 23 and 30 weeks, 90% of which are of normal weight for their gestational age; and a group of less premature, growth-retarded infants from 31 to 36 weeks. We found little or no difference in the distribution of gestational age or the percentage of intrauterine growth rates (IUGR) between black and white infants. In the USA the VLBW rate among black infants is over three times greater than that among white infants and consequently the rates of the three types of VLBW among black infants are likely to be triple those among white infants. 相似文献
6.
BACKGROUND: A simple, rapid, inexpensive method for measuring the flow in a
patient's vascular access would permit routine monitoring during
haemodialysis, and hence provide information of access graft deterioration
sufficiently early to increase the success of minimally invasive remedial
procedures. This paper reports the validation of such a method in animals.
METHODS: A PTFE graft was implanted in sheep between the carotid artery and
the jugular vein. While the sheep was under general anaesthesia and on an
haemodialysis circuit, ultrasound velocity in its blood was perturbed by
the injection of a 5-10 ml bolus of isotonic NaCl. The pump tubing flow was
measured by a transit-time blood flow meter. This flow was combined with
the areas of perturbation generated by the injection before and after
mixing in the access flow to estimate graft flow. The calculated graft flow
was compared to flow measured directly by a transit-time probe on the same
carotid artery. RESULTS: Over a 10-fold range, 120-1260 ml/min, graft flow
measured by ultrasound velocity dilution agreed well with graft flow
measured directly with a scatter of 76 ml/min about the regression line.
CONCLUSION: Ultrasound velocity dilution provides a method for measuring
flow in the graft accurate enough for clinical evaluation of patients on
dialysis.
相似文献
7.
Koppler H.; Pfluger K.-H.; Eschenbach I.; Pfab R.; Birkmann J.; Zeller W.; Holle R.; Steinhauer U. E.; Gropp C.; Oehl S.; Lennert K.; Parwaresch M. R.; Kuhn H.; Drings P.; Gossmann H. H.; Khoury M.; Schubotz R.; Havemann K. 《Annals of oncology》1994,5(1):49-55
Background: With CHOP, the standard protocol of recent decades,about 30% of long-term survival has been reported. A numberof studies using more aggressive multidrug regimens or alternatingchemotherapies have recently suggested higher CR rates and increasedsurvival. In 1989 we reported similar results with a combined-modalitytreatment administering 6 cycles of CHOP supplemented with etoposideand an involved field irradiation for patients in PR or CR. Patients and methods: To confirm the efficacy of this approach,we initiated a prospective randomised trial comparing 4 cyclesof CHOP-VP 16 (CHOEP) with 4 cycles of two alternating regimens,hCHOP and IVEP. One hundred seventy-five patientswith high-grade non-Hodgkin's lymphomas stages II-IV were stratifiedfor age, stage and LDH and randomised to receive either fourcycles of cyclophosphamide, doxorubicin, vincristine, etoposide,prednisolone (CHOEP) in arm A or four cycles of chemotherapywith a dose-intensified CHOP (hCHOP) alternating with ifosfamide,etoposide, vindesine, prednisolone (IVEP) in arm B. After fourcycles of chemotherapy an involved field irradiation with atotal dose of 35 Gy was given to all patients demonstrated tobe in complete or partial remission. Results: Of the 185 randomised patients, 175 were eligible and171 evaluable for response and survival. One hundred forty-sixof the 171 patients (85%) achieved complete remission (CR) with87% and 84% CRs in arms A and B, respectively. With a medianfollow-up of 36 months the estimated overall survival at 2 yearsis 66% and 73% for arms A and B. The percentage of all patientsin first CR is estimated to be 59% and 55% at 2 years for armsA and B, respectively. None of the differences in CR rate, survival,or relapse-free survival are statistically significant. Multivariateanalysis of subgroups incorporating the factors of sex, age,performance status, stage, B symptoms, bulky disease, LDH andhistology revealed that only stage and LDH were factors whichindependently affected outcome. The estimated 2-year survivalrate of patients with stages II, III and IV is predicted tobe 84%, 62% and 52%, respectively. Patients with LDH >250U/I have an estimated survival of 52% at 2 years versus 84%for patients with LDH 相似文献
8.
9.
Nucleic acid spot hybridization with nonradioactive labeled probes in screening for human papillomavirus DNA sequences 总被引:1,自引:0,他引:1
We examined 161 human tissue samples using the spot hybridization technique with nonradioactive labeled DNA probes of human papillomavirus (HPV). Whole cells were spotted on nitrocellulose filters; DNA of the cells was denatured and fixed to the filter. Then the DNA spots were hybridized to nonradioactive labeled DNA and monitored by a sandwich immunoenzymatic reaction. This technique is simple, sensitive, specific, requires no special equipment, and can be used in clinical settings. HPV DNA was found in 92% of samples in which, on the basis of histologic and colposcopic criteria, its presence was suspected, as well as in 31 samples where it was not suspected. 相似文献
10.